AC
MD icon

Aristeia Capital’s Pediatrix Medical MD Stock Holding History

Aristeia Capital’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48,087
Closed -$690K – 589
2025
Q2 		$690K Buy
48,087
+23,612
+96% +$324K 0.02% 186
2025
Q1 		$355K Buy
+24,475
New +$348K 0.01% 228
2024
Q3 		– Sell
-91,033
Closed -$687K – 418
2024
Q2 		$687K Buy
+91,033
New +$753K 0.02% 103

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Aristeia Capital's MD Position: Q3 2025 in Review

Aristeia Capital sold out of Pediatrix Medical (MD) in Q3 2025, closing a stake of 48,087 shares — an estimated $690K sold.

Aristeia Capital first reported a position in MD in Q2 2024 and held it in 3 quarters. The position peaked at $690K in Q2 2025. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.

  • Aristeia Capital reported no remaining Pediatrix Medical position as of Q3 2025 after selling out during the quarter.
  • Aristeia Capital sold 48,087 Pediatrix Medical shares in Q3 2025, an estimated $690K.
  • Aristeia Capital first reported a position in Pediatrix Medical in Q2 2024 and held it in 3 quarters.
  • Aristeia Capital's Pediatrix Medical position peaked at $690K in Q2 2025.
  • 268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.

Based on Aristeia Capital's 13F filing for Q3 2025, filed 14 Nov 2025.